Fisher syndrome with tetraparesis and antibody to GQ1b: Evidence for motor nerve terminal block

Muscle and Nerve

Volumn 22, Issue 5, 1999, Pages 640-644

  Uncini, Antonino ^a   Lugaresi, Alessandra ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Anti GQ1b antibodies; Botulism; Fisher syndrome; Motor nerve terminal block

Indexed keywords

GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN G;

ADULT; ANTIBODY DETECTION; ARTICLE; CASE REPORT; ELECTROMYOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MALE; MOTOR NERVE; MUSCLE WEAKNESS; NERVE CONDUCTION; NEUROPATHY; PRIORITY JOURNAL; QUADRIPLEGIA; SUBCLAVIAN STEAL SYNDROME;

EID: 0032938123     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-4598(199905)22:5<640::aid-mus14>3.0.co;2-%23     Document Type: Article

References (18)

1. Berlit P, Rakicky J. The Miller Fisher syndrome. Review of the literature. J Clin Neuroophthalmol 1992;12:57-63.
2. Buchwald B, Weishaupt A, Toyka KV, Dudel J. Immunoglobulin G from a patient with Miller Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice. Neurosci Lett 1995;201:163-166.
3. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res 1997;745:32-36.
4. Chiba A, Kusunoki S, Obata H, Machimani R, Kanazawa I. Serum anti-GQ1b antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993; 43:1911-1917.
5. Chiba A, Kusunoki S, Shimuzu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker for Miller Fisher syndrome. Ann Neurol 1992;31:677-699.
6. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:57-65.
7. Fross R, Daube J. Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings. Neurology 1987;37: 1493-1498.
8. Jamal G, Ballantyne JP. The localization of the lesion in patients with acute ophthalmoplegia, ataxia and areflexia (Miller Fisher Syndrome). A serial multimodal neurophysiological study. Brain 1988;111:95-114.
9. Keesey JC. Electrodiagnostic approach to defects of neuromuscular transmission. Muscle Nerve 1989;12:613-626.
10. Kornberg AJ, Pestronk A, Blume GM, Lopate G, Yue J, Hahn A. Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes. Neurology 1996;47:1317-1320.
11. Montecucco C, Schiavo G. Structure and function of tetanus and botulinum neurotoxins. Q Rev Biophys 1995;28:423-472.
12. Notermans SWH, Wocke JHJ, van den Berg LH: Botulism and Guillain-Barré syndrome. Lancet 1992;340:303.
13. Oh SJ: Botulism: electrophysiological studies. Ann Neurol 1977;1:481-485.
14. Roberts M, Willison H, Vincent A, Newsom-Davies J. Serum factor in Miller Fisher variant of a Guillain-Barré syndrome and neurotransmitter release. Lancet 1994;343:454-455.
15. Trojaborg W. Early electrophysiologic changes in conduction block. Muscle Nerve 1978;400-403.
16. Willison HJ, Kennedy PGE. Gangliosides and bacterial toxins in Guillain-Barré syndrome. J Neuroimmunol 1993;46: 105-112.
17. Willison HJ, Veitch J, Paterson G, Kennedy PGE. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 1993;56:204-206.
18. Yuki N, Sato S, Tsuji S, Ohsawa T, Miyatake T. Frequent presence of anti-GQ1b antibody in Miller Fisher's syndrome. Neurology 1993;43:414-417.